Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Sysmex Corporation ADR (SSMXY : OTC)
 
 • Company Description   
Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $30.89 Daily Weekly Monthly
20 Day Moving Average: 63,832 shares
Shares Outstanding: 419.32 (millions)
Market Capitalization: $12,952.64 (millions)
Beta: 0.42
52 Week High: $69.41
52 Week Low: $29.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.95% 0.28%
12 Week -16.56% -8.27%
Year To Date -54.42% -44.26%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1-5-1 Wakinohama-Kaigandori Chuo-ku
-
Kobe,M0 651-0073
JPN
ph: 817-8265-0500
fax: 817-8265-0524
None http://www.sysmex.co.jp
 
 • General Corporate Information   
Officers
Hisashi Ietsugu - Chief Executive Officer and Chairman
Yukio Nakajima - Senior Executive Officer; Senior Managing Director
Kaoru Asano - Director
Kazuya Obe - Director
Mitsuru Watanabe - Director

Peer Information
Sysmex Corporation ADR (ABMD)
Sysmex Corporation ADR (DMDS)
Sysmex Corporation ADR (CPWY.)
Sysmex Corporation ADR (EQUR)
Sysmex Corporation ADR (ECIA)
Sysmex Corporation ADR (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 87184P109
SIC: 8880
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 05/25/22
Share - Related Items
Shares Outstanding: 419.32
Most Recent Split Date: (:1)
Beta: 0.42
Market Capitalization: $12,952.64 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.77%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.24
Current Fiscal Year EPS Consensus Estimate: $1.09 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/25/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 28.34
Trailing 12 Months: 32.52
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 23.40
Price / Sales: 4.07
EPS Growth
vs. Year Ago Period: 50.00%
vs. Previous Quarter: 22.73%
Sales Growth
vs. Year Ago Period: 20.40%
vs. Previous Quarter: 11.99%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - 13.96
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - 10.24
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - 12.49
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - 12.49
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©